April 4, 2017 / 2:31 AM / 6 months ago

BRIEF-Prescient Therapeutics seeks trading halt

April 4 (Reuters) - Prescient Therapeutics Ltd:

* Requests trading halt pending an announcement to market in relation to results from company’s phase 1b breast cancer trial Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below